BlackRock Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.38M | Sell |
36,732
-13,139
| -26% | -$492K | ﹤0.01% | 2474 |
|
|
2016
Q3 | $3.38M | Sell |
49,871
-4,185
| -8% | -$284K | ﹤0.01% | 1765 |
|
|
2016
Q2 | $3M | Buy |
54,056
+11,114
| +26% | +$617K | ﹤0.01% | 1806 |
|
|
2016
Q1 | $2.7M | Buy |
42,942
+2,278
| +6% | +$143K | ﹤0.01% | 1790 |
|
|
2015
Q4 | $3.83M | Sell |
40,664
-481
| -1% | -$45.3K | ﹤0.01% | 1584 |
|
|
2015
Q3 | $3.31M | Sell |
41,145
-4,268
| -9% | -$343K | ﹤0.01% | 1674 |
|
|
2015
Q2 | $5.44M | Buy |
45,413
+12,621
| +38% | +$1.51M | 0.01% | 1425 |
|
|
2015
Q1 | $3.42M | Buy |
32,792
+8,996
| +38% | +$939K | ﹤0.01% | 1658 |
|
|
2014
Q4 | $2.31M | Sell |
23,796
-503
| -2% | -$48.8K | ﹤0.01% | 1923 |
|
|
2014
Q3 | $1.9M | Sell |
24,299
-344
| -1% | -$26.9K | ﹤0.01% | 2024 |
|
|
2014
Q2 | $1.56M | Sell |
24,643
-138,082
| -85% | -$8.72M | ﹤0.01% | 2278 |
|
|
2014
Q1 | $10.9M | Buy |
162,725
+935
| +0.6% | +$62.8K | 0.02% | 867 |
|
|
2013
Q4 | $10.4M | Sell |
161,790
-3,956
| -2% | -$254K | 0.02% | 881 |
|
|
2013
Q3 | $10.6M | Buy |
165,746
+9,505
| +6% | +$608K | 0.02% | 805 |
|
|
2013
Q2 | $4.84M | Buy |
+156,241
| New | +$4.84M | 0.01% | 1234 |
|